The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
The epidemiology of glucocorticoid-associated adverse events
Abstract
PURPOSE OF REVIEW: The introduction of glucocorticoid therapy by Dr Philip Hench in the 1950s revolutionized the treatment of rheumatic and inflammatory disease. These preparations remain an important component of therapy for a variety of diseases. As with any potent medication, however, they are not without side effects. Analysis of physician understanding and practice suggest that appreciation for the frequency and significant morbidity associated with glucocorticoids is poor. The purpose of this review is to provide an update on the most recent literature regarding glucocorticoid use and associated adverse events. RECENT FINDINGS: Recent studies suggest that adverse events such as weight gain, skin thinning, sleep disturbance and neuropsychiatric disorders may occur in patients taking glucocorticoids. Adverse events may occur even in low-dose therapy and appear to be dose and duration dependent. Glucocorticoid-induced osteoporosis is a potentially preventable complication but physician adherence to preventive guidelines is poor. New data reinforce the understanding that glucocorticoids significantly increase the risk of infection. There are strong data-driven concerns about the increased susceptibility of children and possibly even neonates to glucocorticoid-associated adverse events. SUMMARY: Glucocorticoid therapy, while important in the treatment of a variety of serious inflammatory diseases, causes significant morbidity among long term users.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress Syndrome
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa051693 · Cited by 1,498
Use of Inhaled Corticosteroids and Risk of Fractures
Van Staa, T. P., Leufkens, H. G. M., & Cooper, C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,308
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis
Staa, T. P. V., Staa, T. P. V., Staa, T. P. V., Leufkens, H. G. M., & Cooper, C. (2002) · Osteoporosis International · doi:10.1007/s001980200108 · Cited by 1,294
Use of oral corticosteroids and risk of fractures
Van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.993 · Cited by 1,263
Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry
Lichtenstein, G. R., Feagan, B. G., Cohen, R. D., Salzberg, B. A., Diamond, R. H., Chen, D. M., Pritchard, M. L., & Sandborn, W. J. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.002 · Cited by 905
A meta-analysis of prior corticosteroid use and fracture risk.
Kanis, J. A., Johansson, H., Oden, A., Johnell, O., de Laet, C., Melton, L. J., Tenenhouse, A., Reeve, J., Silman, A. J., Pols, H. A., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040134 · Cited by 839
Seckl, J. R., & Holmes, M. C. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0515 · Cited by 754
Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease
Wei, L., MacDonald, T. M., & Walker, B. R. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00007 · Cited by 730
Population‐based assessment of adverse events associated with long‐term glucocorticoid use
Curtis, J. R., Westfall, A. O., Allison, J., Bijlsma, J. W., Freeman, A., George, V., Kovac, S. H., Spettell, C. M., & Saag, K. G. (2006) · Arthritis Care & Research · doi:10.1002/art.21984 · Cited by 595
Self-citationPredictors of infection in rheumatoid arthritis
Doran, M. F., Crowson, C. S., Pond, G. R., O'Fallon, W. M., & Gabriel, S. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10529 · Cited by 560
Van Staa, T. P., Laan, R. F., Barton, I. P., Cohen, S., Reid, D. M., & Cooper, C. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11283 · Cited by 559
Use of oral corticosteroids in the United Kingdom
van Staa, T. P. (2000) · QJM · doi:10.1093/qjmed/93.2.105 · Cited by 529
Da Silva, J. A. P., Jacobs, J. W. G., Kirwan, J. R., Boers, M., Saag, K. G., Inês, L. B. S., de Koning, E. J. P., Buttgereit, F., Cutolo, M., Capell, H., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.038638 · Cited by 522
Self-citationSouverein, P. C., Berard, A., Van Staa, T. P., Cooper, C., Egberts, A. C. G., Leufkens, H. G. M., & Walker, B. R. (2004) · Heart · doi:10.1136/hrt.2003.020180 · Cited by 482
Wolfe, F., Caplan, L., & Michaud, K. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21568 · Cited by 480
Glucocorticoid use, other associated factors, and the risk of tuberculosis
Jick, S. S., Lieberman, E. S., Rahman, M. U., & Choi, H. K. (2006) · Arthritis Care & Research · doi:10.1002/art.21705 · Cited by 477
Hoes, J. N., Jacobs, J. W. G., Boers, M., Boumpas, D., Buttgereit, F., Caeyers, N., Choy, E. H., Cutolo, M., Da Silva, J. A. P., Esselens, G., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.072157 · Cited by 411
Self-citationAngeli, A., Guglielmi, G., Dovio, A., Capelli, G., de Feo, D., Giannini, S., Giorgino, R., Moro, L., & Giustina, A. (2006) · Bone · doi:10.1016/j.bone.2006.02.005 · Cited by 365
Glucocorticoid-induced osteoporosis: an update
Mazziotti, G., Angeli, A., Bilezikian, J. P., Canalis, E., & Giustina, A. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.03.009 · Cited by 362
Schneeweiss, S., Setoguchi, S., Weinblatt, M. E., Katz, J. N., Avorn, J., Sax, P. E., Levin, R., & Solomon, D. H. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22600 · Cited by 302
Fracture risk with intermittent high‐dose oral glucocorticoid therapy
De Vries, F., Bracke, M., Leufkens, H. G. M., Lammers, J. J., Cooper, C., & Van Staa, T. P. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22294 · Cited by 298
Glucocorticoid action networks and complex psychiatric and/or somatic disorders
Chrousos, G. P., & Kino, T. (2007) · Stress · doi:10.1080/10253890701292119 · Cited by 292
Crowther, C. A., Haslam, R. R., Hiller, J. E., Doyle, L. W., & Robinson, J. S. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68846-6 · Cited by 288
Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy
King, W. M., Ruttencutter, R., Nagaraja, H. N., Matkovic, V., Landoll, J., Hoyle, C., Mendell, J. R., & Kissel, J. T. (2007) · Neurology · doi:10.1212/01.wnl.0000260974.41514.83 · Cited by 283
Oral glucocorticoid use is associated with an increased risk of fracture
Steinbuch, M., Youket, T. E., & Cohen, S. (2004) · Osteoporosis International · doi:10.1007/s00198-003-1548-3 · Cited by 277
Corticosteroid-induced clinical adverse events: frequency, risk factors and patient?s opinion
Fardet, L., Flahault, A., Kettaneh, A., Tiev, K. P., Généreau, T., Tolédano, C., Lebbé, C., & Cabane, J. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07950.x · Cited by 273
Treatment of rheumatoid arthritis
Gaffo, A., Saag, K. G., & Curtis, J. R. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050514 · Cited by 266
Self-citationThe Pathogenesis, Epidemiology and Management of Glucocorticoid-Induced Osteoporosis
van Staa, T. P. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0019-1 · Cited by 260
Children and the Risk of Fractures Caused by Oral Corticosteroids
van Staa, T., Cooper, C., Leufkens, H., & Bishop, N. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.5.913 · Cited by 233
(2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000227087.51641.f3 · Cited by 214
Franklin, J., Lunt, M., Bunn, D., Symmons, D., & Silman, A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.057265 · Cited by 159
Gudbjornsson, B., Juliusson, U. I., & Gudjonsson, F. V. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.1.32 · Cited by 152
Natsui, K., Tanaka, K., Suda, M., Yasoda, A., Sakuma, Y., Ozasa, A., Ozaki, S., & Nakao, K. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1923-3 · Cited by 126
Glucocorticoid-induced osteoporosis in children: impact of the underlying disease
Leonard, M. B. (2007) · PEDIATRICS · doi:10.1542/peds.2006-2023j · Cited by 123
Glucocorticoids and the ageing hippocampus
Hibberd, C. J., Yau, J. L. W., & Seckl, J. R. (2000) · Journal of Anatomy · doi:10.1046/j.1469-7580.2000.19740553.x · Cited by 113
Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica
Kremers, H. M., Reinalda, M. S., Crowson, C. S., Davis, J. M., Hunder, G. G., & Gabriel, S. E. (2007) · Arthritis Care & Research · doi:10.1002/art.22548 · Cited by 105
Walther, F., Fusch, C., Radke, M. H., Beckert, S., & Findeisen, A. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000228105.91240.80 · Cited by 100
Lee, C., Almagor, O., Dunlop, D. D., Manzi, S., Spies, S., Chadha, A., & Ramsey‐Goldman, R. (2005) · Rheumatology · doi:10.1093/rheumatology/kei079 · Cited by 83
Lee, H. J., Oran, B., Saliba, R. M., Couriel, D., Shin, K. Y., Massey, P. R., Neumann, J. L., de Lima, M., Champlin, R. E., & Giralt, S. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705435 · Cited by 73
Trends in prevention of glucocorticoid-induced osteoporosis.
Saag, K. G., Gehlbach, S. H., Curtis, J. R., Youket, T. E., Worley, K., & Lange, J. L. (2006) · PubMed · Cited by 63
Self-citationGlucocorticoid-Induced Bone Loss in Dermatologic Patients: An Update
Summey, B. T., & Yosipovitch, G. (2006) · Archives of Dermatology · doi:10.1001/archderm.142.1.82 · Cited by 51
The cost of glucocorticoid-associated adverse events in rheumatoid arthritis
Pisu, M., James, N. I., Sampsel, S., & Saag, K. G. (2005) · Rheumatology · doi:10.1093/rheumatology/keh594 · Cited by 48
Self-citationGlucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment
Popp, A. W., Isenegger, J., Buergi, E. M., Buergi, U., & Lippuner, K. (2006) · European Spine Journal · doi:10.1007/s00586-005-0056-x · Cited by 41
Depression After Lung Transplantation: Causes and Treatment
Fusar‐Poli, P., Lazzaretti, M., Ceruti, M., Hobson, R. W., Petrouska, K., Cortesi, M., Pozzi, E., & Politi, P. (2007) · Lung · doi:10.1007/s00408-006-0093-1 · Cited by 39
Effect of two prednisone exposures on mood and declarative memory
Brown, E. S., Beard, L., Frol, A. B., & Rush, A. J. (2006) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2005.12.009 · Cited by 30
Cited by
Russell, G., & Lightman, S. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0228-0 · Cited by 1,032
Clinical Practice Guideline: Sudden Hearing Loss
Stachler, R. J., Chandrasekhar, S. S., Archer, S. M., Rosenfeld, R. M., Schwartz, S. R., Barrs, D. M., Brown, S. R., Fife, T. D., Ford, P., Ganiats, T. G., et al. (2012) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599812436449 · Cited by 971
Clinical Practice Guideline: Sudden Hearing Loss (Update)
Chandrasekhar, S. S., Tsai Do, B. S., Schwartz, S. R., Bontempo, L. J., Faucett, E. A., Finestone, S. A., Hollingsworth, D. B., Kelley, D. M., Kmucha, S. T., Moonis, G., et al. (2019) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599819859885 · Cited by 931
Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide
Grossman, S. A., Ye, X., Lesser, G., Sloan, A., Carraway, H., Desideri, S., & Piantadosi, S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0774 · Cited by 578
Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
Järveläinen, H., Sainio, A., Koulu, M., Wight, T. N., & Penttinen, R. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001289 · Cited by 566
Metadata
- Authors
- McDonough, A. K., Curtis, J. R., & Saag, K. G.
- Venue
- Current Opinion in Rheumatology
- Published
- 2008-03
- Volume
- 20
- Issue
- 2
- Pages
- 131-137
- ISSN
- 1040-8711 (ISSN-L)
- OpenAlex
- W2047008569
- Cited by
- 405
- References
- 45
- FWCI
- 16.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.